Enzon Pharmaceuticals, INC. (ENZN) SEC Filings — 2024
14 SEC filings for Enzon Pharmaceuticals, INC. (ENZN) in 2024.
Filings
- Amneal Pharmaceuticals to Acquire Enzon Pharmaceuticals — 8-K · Dec 27, 2024
- Enzon Pharma Files 3Q 2024 10-Q — 10-Q · Nov 5, 2024
- Enzon Pharmaceuticals 8-K: Shareholder Vote Update — 8-K · Oct 1, 2024
- Icahn Entities Amend Enzon Pharmaceuticals Stake Filing — SC 13D/A · Aug 19, 2024
- Enzon Pharmaceuticals Files Q2 2024 10-Q Report — 10-Q · Aug 8, 2024
- Enzon Pharmaceuticals Files 2024 Proxy Statement — DEF 14A · Aug 8, 2024
- Enzon Pharmaceuticals Files 8-K/A on Shareholder Nominations — 8-K/A · Jul 11, 2024
- Enzon Pharmaceuticals Files 8-K on Shareholder Nominations — 8-K · Jul 2, 2024
- Amneal Pharmaceuticals to Acquire Enzon Pharmaceuticals — 8-K · Jun 14, 2024
- Enzon Pharmaceuticals Enters Material Definitive Agreement — 8-K · May 22, 2024
- Enzon Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Enzon Pharmaceuticals Files 10-K/A Amendment for Fiscal Year Ended December 31, 2023 — 10-K/A · Apr 26, 2024
- Enzon Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 20, 2024
- ENZON PHARMACEUTICALS Files Administrative 8-K on Dec 31 Event — 8-K · Jan 5, 2024